EMA Authorised: Enbrel (etanercept) — Pfizer Europe MA EEIG

View source ↗

Summary

The European Medicines Agency authorised Enbrel (etanercept) for multiple inflammatory diseases including rheumatoid arthritis, ankylosing spondylitis, psoriati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Juvenile Idiopathic Arthritis
• Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Status: Authorised. Therapeutic area: Spondylitis, Ankylosing;Arthritis, Juvenile Rheumatoid;Arthritis, Psoriatic;Psoriasis;Arthritis, Rheumatoid. MAH: Pfizer Europe MA EEIG. Decision date: 10/07/2025